NCT06744673View on ClinicalTrials.gov

A Study to Assess the Pregnancy Outcome in Women Exposed to Dayvigo® During Pregnancy Compared to an Unexposed Control Population

Active, not recruitingOBSERVATIONAL

Enrollment

861

Participants

Timeline

Start Date

January 3, 2025

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions

Sleep Initiation and Maintenance DisordersPregnancy

Interventions

OTHER

No Intervention

This is a non-interventional study.

Trial Locations (1)

07110

Eisai Trial Site #1, Nutley

All Listed Sponsors

lead

Eisai Inc.

INDUSTRY